Health Condition 1: null- Diabetic Dyslipidemia
Conditions
Interventions
Intervention1: pitavastatin: one/two Pitavastatin 2 mg tablets per day preferably in the morning for 12 weeks
Sponsors
Cadila Healthcare
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex, 18-75 years of age.. 2. Patients who are diagnosed of Type 2 Diabetes 3. Patients with any one of the following: serum Low density Lipoprotein (LDL) cholesterol > 100 mg/dl, Or serum high density lipoprotein (HDL) cholesterol 150 mg/dl
Exclusion criteria
Exclusion criteria: Patients who is: 1. Known to have hypersensitivity to pitavastatin 2. Having active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels 3. Pregnant woman or may become pregnant in next 3 months 4. Nursing mother 5. on cyclosporine 6. Has change/titration in anti-diabetic medications in last one month 7. On statin or other lipid lowering therapy during last 3 months 8. creatinine clearance 9. not willing to give written consent for enrollment in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the serum LDL cholesterol levels compared to baseline levels. Timepoint: Change in the serum LDL cholesterol levels compared to baseline levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in the serum total cholesterol levels at 3 months compared to baseline levels. Change in the serum HDL cholesterol levels at 3 months compared to baseline levels. Change in the serum Triglycerides levels at 3 months compared to baseline levelsTimepoint: At 3 months | — |
Countries
India
Contacts
Public ContactDr Samir Prajapati
Cadila Healthcare
Outcome results
None listed